VANGUARD BD INDEX FDS - INTERMED TERM (BIV)

Historical Holders from Q1 2014 to Q4 2025

Symbol
BIV
Type / Class
Equity / INTERMED TERM
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
202,943,009
Holdings value
$15,845,039,720
% of all portfolios
0.11%
Number of holders
914
Number of buys
510
Number of sells
333
Average buys %
+0.01%
Average sells %
-0.01%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
As of 30 Sep 2025 VANGUARD BD INDEX FDS - INTERMED TERM (BIV) has 914 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 202,943,009 shares of the company stock as of 30 Sep 2025.

Institutional Holders of VANGUARD BD INDEX FDS - INTERMED TERM (BIV) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 1,865,643 $145,303,507 -$17,676,830 $77.88 19
2025 Q3 202,943,009 $15,845,039,720 +$1,406,521,753 $78.09 914
2025 Q2 191,277,241 $14,787,180,384 +$379,178,702 $77.34 924
2025 Q1 186,420,550 $14,268,829,633 +$1,039,958,609 $76.57 913
2024 Q4 172,354,770 $12,880,323,877 +$1,022,095,049 $74.73 919
2024 Q3 156,335,780 $12,243,121,407 +$601,265,807 $78.37 844
2024 Q2 148,212,836 $11,101,032,458 +$333,307,020 $74.89 801
2024 Q1 142,613,454 $10,747,516,788 +$41,402,670 $75.40 799
2023 Q4 866,833 $66,208,652 +$2,481,241 $76.38 17
2023 Q3 131,700,738 $9,522,908,868 +$166,326,189 $72.31 696
2023 Q2 124,865,646 $9,394,305,623 +$954,367,457 $75.23 701
2023 Q1 113,034,452 $8,674,633,086 +$482,576,131 $76.74 683
2022 Q4 101,692,116 $7,563,497,815 +$160,216,099 $74.32 664
2022 Q3 104,142,082 $7,652,912,403 +$1,113,309,058 $73.48 637
2022 Q2 87,069,557 $6,762,921,076 -$133,824,766 $77.65 655
2022 Q1 87,298,160 $7,143,292,846 -$42,614,024 $81.90 694
2021 Q4 89,398,957 $7,829,652,774 -$185,227,877 $87.62 708
2021 Q3 88,834,805 $7,946,554,981 +$287,538,888 $89.44 624
2021 Q2 86,189,510 $7,754,401,281 -$21,874,825 $89.96 622
2021 Q1 83,724,775 $7,422,261,886 -$783,451,483 $88.73 615
2020 Q4 95,165,579 $8,828,691,054 +$123,235,751 $92.85 638
2020 Q3 92,283,931 $8,625,639,017 +$1,004,973,692 $93.48 552
2020 Q2 82,104,007 $7,652,214,322 +$326,722,796 $93.19 518
2020 Q1 76,766,854 $6,856,359,078 -$2,115,886,240 $89.33 485
2019 Q4 101,091,756 $8,818,765,644 +$368,250,024 $87.22 469
2019 Q3 96,703,236 $8,506,915,604 -$3,794,911 $88.00 401
2019 Q2 96,028,162 $8,306,059,678 +$258,044,559 $86.50 413
2019 Q1 93,775,290 $7,870,722,491 -$1,812,307,060 $83.93 392
2018 Q4 115,078,491 $9,353,490,965 +$417,504,705 $81.29 400
2018 Q3 109,086,592 $8,778,593,399 -$647,023,854 $80.48 374
2018 Q2 117,044,501 $9,476,887,302 -$1,253,958,291 $80.97 379
2018 Q1 132,541,025 $10,830,629,171 +$321,196,950 $81.77 394
2017 Q4 125,433,920 $10,514,899,410 +$580,340,790 $83.83 398
2017 Q3 117,821,227 $9,974,469,641 +$3,374,743,625 $84.66 343
2017 Q2 77,863,633 $6,582,457,623 -$611,184,911 $84.53 331
2017 Q1 88,634,898 $7,411,353,905 +$721,392,150 $83.61 330
2016 Q4 79,986,788 $6,645,003,817 -$755,133,723 $83.07 322
2016 Q3 88,406,102 $7,748,384,559 +$360,676,894 $87.66 311
2016 Q2 84,447,885 $7,436,863,494 +$1,121,710,171 $88.07 294
2016 Q1 71,456,812 $6,163,399,159 +$454,720,767 $86.27 276
2015 Q4 66,069,236 $5,488,688,296 +$805,778,965 $83.06 262
2015 Q3 54,689,496 $4,628,377,574 +$1,846,135,782 $84.84 232
2015 Q2 47,230,026 $3,963,229,498 +$268,907,786 $83.87 223
2015 Q1 44,017,564 $3,794,557,057 +$702,288,015 $86.21 218
2014 Q4 35,730,736 $3,026,091,213 +$153,424,084 $84.68 200
2014 Q3 31,200,980 $2,629,189,598 +$237,239,319 $84.26 175
2014 Q2 28,380,575 $2,403,542,831 +$449,007,994 $84.69 171
2014 Q1 23,077,751 $1,922,859,596 -$383,824,906 $83.33 162